2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | ENDOCRINE-RELATED CANCER ENDOCR-RELAT CANCER LetPub评分 7.4
50人评分
我要评分
声誉 8.8 影响力 6.5 速度 7.0 | |||||||||||||||||||||||||||||
| 期刊ISSN | 1351-0088 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 5.900 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||
| 2021-2022自引率 | 3.40%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
| h-index | 119 | |||||||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||||||
| 期刊简介 | Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society. Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics. Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered. | |||||||||||||||||||||||||||||
| 期刊官方网站 | http://erc.endocrinology-journals.org/ | |||||||||||||||||||||||||||||
| 期刊投稿网址 | http://www.endocrinology-journals.org/site/misc/submit-online.xhtml | |||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足ENDOCRINE-RELATED CANCER的语言要求，还能让ENDOCRINE-RELATED CANCER编辑和审稿人得到更好的审稿体验，让稿件最大限度地被ENDOCRINE-RELATED CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||
| 通讯方式 | BIOSCIENTIFICA LTD, EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL, ENGLAND, BS324JT | |||||||||||||||||||||||||||||
| 出版商 | BioScientifica Ltd. | |||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-内分泌学与代谢 | |||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||
| 出版周期 | Quarterly | |||||||||||||||||||||||||||||
| 出版年份 | 1994 | |||||||||||||||||||||||||||||
| 年文章数 | 98点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
| Gold OA文章占比 | 14.29% | |||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 64.29% | |||||||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1351-0088%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 一般 | |||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在ENDOCRINE-RELATED CANCER顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ. Author: Xekouki P1,2, Lodge EJ1,3, Matschke J4, Santambrogio A1,5, Apps JR6,7, Sharif A8, Jacques TS6,7, Aylwin S2, Prevot V8, Li R9, Flitsch J10, Bornstein SR3,5, Theodoropoulou M11, Andoniadou CL1,5. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):215-225. doi: 10.1530/ERC-18-0330. PubMed DOI |
| 2. | Antitumor effects of anlotinib in thyroid cancer. Author: Ruan X1, Shi X2, Dong Q2, Yu Y1, Hou X1, Song X2, Wei X3, Chen L2, Gao M1. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):153-164. doi: 10.1530/ERC-17-0558. PubMed DOI |
| 3. | KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer. Author: Luo XH1, Liu JZ1, Wang B1, Men QL1, Ju YQ1, Yin FY1, Zheng C1, Li W2. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):181-195. doi: 10.1530/ERC-18-0383. PubMed DOI |
| 4. | Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer. Author: Guan W1, Hu J1,2,3, Yang L4, Tan P4, Tang Z4, West BL5, Bollag G5, Xu H1, Wu L3,6,7,8,9. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):131-140. doi: 10.1530/ERC-18-0284. PubMed DOI |
| 5. | ATM deficiency promotes progression of CRPC by enhancing Warburg effect. Author: Xu L1,2, Ma E3, Zeng T2,4, Zhao R5, Tao Y2, Chen X2, Groth J2, Liang C1, Hu H2,6, Huang J2,6,7. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196. PubMed DOI |
| 6. | KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC. Author: Wei X1, Cai S2,3, Boohaker RJ2, Fried J2, Li Y4, Hu L5, Pan Y5, Cheng R5, Zhang S1, Tian Y3, Gao M5, Xu B2,6. Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):141-151. doi: 10.1530/ERC-18-0193. PubMed DOI |
| 7. | SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer. Author: Han F1, Liu WB2, Li JJ3, Zhang MQ4, Yang JT5, Zhang X6, Hao XL7, Yin L8, Mao CY9, Jiang X10, Cao J11, Liu JY12. Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0529.R1. doi: 10.1530/ERC-18-0529. [Epub ahead of print] PubMed DOI |
| 8. | Roles of the HOXA10 gene during castrate-resistant prostate cancer progression. Author: Long Z1,2, Li Y2, Gan Y2,3, Zhao D4,5,6, Wang G4,5,6, Xie N2, Lovnicki JM2, Fazli L2, Cao Q7, Chen K4,5,6, Dong X2. Journal: Endocr Relat Cancer. 2019 Mar 1;26(3):279-292. doi: 10.1530/ERC-18-0465. PubMed DOI |
| 9. | Targeting autophagy in thyroid cancers. Author: Wei WJ1, Hardin H2, Luo QY3. Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0502.R1. doi: 10.1530/ERC-18-0502. [Epub ahead of print] PubMed DOI |
| 10. | Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Author: Wu F1, Li F2, Lin X3, Xu F4, Cui R5, Zhong J6, Zhu T7, Shan SK8, Liao XB9, Yuan L10, Mo Z11. Journal: Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0008.R1. doi: 10.1530/ERC-19-0008. [Epub ahead of print] PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共1条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
